President Donald Trump scored yet another victory in his legal battle against the members of the Pulitzer Prize Board after a judge denied their request for a temporary stay on his lawsuit against ...

A blanket of snow covers the ground and icicles hang from the eaves, but inside the fire is blazing and it seems like every room has a candle lit. She has been in the area for about eight years ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

Insurers generally cover Lilly's and Novo's drugs for diabetes, but many do not cover the weight-loss medications. That has led many patients to pay out of pocket for compounded versions ...

A UK start­up that wants to bring pro­tein de­graders to the neu­rode­gen­er­a­tion field has closed a $31 mil­lion seed round.

Chang later returned home on the same road where hours earlier he’d hit Lilly Glaubach. He spent one more night with his wife and daughter before police knocked on his door after a Good ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

When it comes to swapping one’s wardrobe for the warm weather, Lilly Pulitzer is often a go-to ... A vibrant print covers the sole, paired with a solid jelly upper. Match ythe sandals to ythe ...

Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.